New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine

被引:25
作者
Wang, Nana [1 ]
Mei, Haibo [1 ]
Dhawan, Gagan [2 ,3 ,4 ]
Zhang, Wei [5 ]
Han, Jianlin [1 ]
Soloshonok, Vadim A. [6 ,7 ]
机构
[1] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat Fo, Nanjing 210037, Peoples R China
[2] Delhi Skill & Entrepreneurship Univ, Sch Allied Med Sci, New Delhi 110075, India
[3] Univ Delhi, Acharya Narendra Dev Coll, Dept Biomed Sci, New Delhi 110019, India
[4] Univ Delhi, Inst Eminence, Delhi Sch Skill Enhancement & Entrepreneurship Dev, Delhi 110007, India
[5] Univ Massachusetts Boston, Dept Chem, 100 Morrissey Blvd, Boston, MA 02125 USA
[6] Univ Basque Country UPV EHU, Fac Chem, Dept Organ Chem 1, Paseo Manuel Lardizabal 3, San Sebastian 20018, Spain
[7] Basque Fdn Sci, IKERBASQUE, Alameda Urquijo 36 5, Bilbao 48011, Spain
基金
中国国家自然科学基金;
关键词
fluorine-containing compounds; blockbuster drugs; pharmaceuticals; drug design and development; tailor-made amino acids; ASYMMETRIC-SYNTHESIS; HELICOBACTER-PYLORI; KINETIC RESOLUTION; PSMA INHIBITOR; TRIPLE THERAPY; VONOPRAZAN; DERIVATIVES; DISCOVERY; AGONIST; BLOCKER;
D O I
10.3390/molecules28093651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The strategic fluorination of oxidatively vulnerable sites in bioactive compounds is a relatively recent, widely used approach allowing us to modulate the stability, bio-absorption, and overall efficiency of pharmaceutical drugs. On the other hand, natural and tailor-made amino acids are traditionally used as basic scaffolds for the development of bioactive molecules. The main goal of this review article is to emphasize these general trends featured in recently approved pharmaceutical drugs.
引用
收藏
页数:21
相关论文
共 132 条
[1]   New prodrug approach for amino acids and amino-acid-like drugs [J].
AboulFadl, T ;
ElShorbagi, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (02) :165-169
[2]   Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers [J].
Anderson, Robert L. ;
Trivedi, Darshan V. ;
Sarkar, Saswata S. ;
Henze, Marcus ;
Ma, Weikang ;
Gong, Henry ;
Rogers, Christopher S. ;
Gorham, Joshua M. ;
Wong, Fiona L. ;
Morck, Makenna M. ;
Seidman, Jonathan G. ;
Ruppel, Kathleen M. ;
Irving, Thomas C. ;
Cooke, Roger ;
Green, Eric M. ;
Spudich, James A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (35) :EB143-EB152
[3]  
[Anonymous], 2022, FDA APPR NEW HIV DRU
[4]   Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB) [J].
Arikawa, Yasuyoshi ;
Nishida, Haruyulci ;
Kurasawa, Osamu ;
Hasuoka, Atsushi ;
Hirase, Keizo ;
Inatomi, Nobuhiro ;
Hori, Yasunobu ;
Matsukawa, Jun ;
Imanishi, Akio ;
Kondo, Mitsuyo ;
Tarui, Naoki ;
Hamada, Teruki ;
Takagi, Terufumi ;
Takeuchi, Toshiyuki ;
Kajino, Masahiro .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (09) :4446-4456
[5]   Effects of mavacamten on Ca2+sensitivity of contraction as sarcomere length varied in human myocardium [J].
Awinda, Peter O. ;
Bishaw, Yemeserach ;
Watanabe, Marissa ;
Guglin, Maya A. ;
Campbell, Kenneth S. ;
Tanner, Bertrand C. W. .
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (24) :5609-5621
[6]  
Baranyai Z., 2020, Patent No. [WO2020030618A1, 2020030618]
[7]  
Begue J.-P., 2008, Bioorganic and medicinal chemistry of fluorine
[8]   Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer [J].
Benesova, Martina ;
Schaefer, Martin ;
Bauder-Wuest, Ulrike ;
Afshar-Oromieh, Ali ;
Kratochwil, Clemens ;
Mier, Walter ;
Haberkorn, Uwe ;
Kopka, Klaus ;
Eder, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (06) :914-920
[9]   Structural and mechanistic bases for a potent HIV-1 capsid inhibitor [J].
Bester, Stephanie M. ;
Wei, Guochao ;
Zhao, Haiyan ;
Adu-Ampratwum, Daniel ;
Iqbal, Naseer ;
Courouble, Valentine V. ;
Francis, Ashwanth C. ;
Annamalai, Arun S. ;
Singh, Parmit K. ;
Shkriabai, Nikoloz ;
Van Blerkom, Peter ;
Morrison, James ;
Poeschla, Eric M. ;
Engelman, Alan N. ;
Melikyan, Gregory B. ;
Griffin, Patrick R. ;
Fuchs, James R. ;
Asturias, Francisco J. ;
Kvaratskhelia, Mamuka .
SCIENCE, 2020, 370 (6514) :360-+
[10]   Sotorasib: First Approval [J].
Blair, Hannah A. .
DRUGS, 2021, 81 (13) :1573-1579